APO Research
Talk to an analyst

APO RESEARCH · REPORT

PD-L1 Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global PD-L1 Inhibitors Market Analysis and Forecast 2026-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchPD-L1 Inhibitors Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal PD-L1 Inhibitors Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal PD-L1 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PD-L1 Inhibitors Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal PD-L1 Inhibitors Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global PD-L1 Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for PD-L1 Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for PD-L1 Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for PD-L1 Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for PD-L1 Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of PD-L1 Inhibitors include Merck KGaA, Roche and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for PD-L1 Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of PD-L1 Inhibitors, also provides the sales of main regions and countries. Of the upcoming market potential for PD-L1 Inhibitors, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the PD-L1 Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global PD-L1 Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for PD-L1 Inhibitors sales, projected growth trends, production technology, application and end-user industry.

PD-L1 Inhibitors Segment by Company

Merck KGaA

Roche

AstraZeneca

PD-L1 Inhibitors Segment by Type

TECENTRIQ

Imfinzi

Bavencio

PD-L1 Inhibitors Segment by Application

Retail Pharmacy

Hospital Pharmacy

Other

PD-L1 Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PD-L1 Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PD-L1 Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PD-L1 Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of PD-L1 Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of PD-L1 Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PD-L1 Inhibitors sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global PD-L1 Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. TECENTRIQ Major Manufacturers Table 3. Imfinzi Major Manufacturers Table 4. Bavencio Major Manufacturers Table 5. Global PD-L1 Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Retail Pharmacy Major Manufacturers Table 7. Hospital Pharmacy Major Manufacturers Table 8. Other Major Manufacturers Table 9. PD-L1 Inhibitors Industry Trends Table 10. PD-L1 Inhibitors Industry Drivers Table 11. PD-L1 Inhibitors Industry Opportunities and Challenges Table 12. PD-L1 Inhibitors Industry Restraints Table 13. Global PD-L1 Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global PD-L1 Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 15. Global PD-L1 Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 16. Global PD-L1 Inhibitors Revenue Market Share by Region (2021-2026) Table 17. Global PD-L1 Inhibitors Revenue Market Share by Region (2027-2032) Table 18. Global PD-L1 Inhibitors Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global PD-L1 Inhibitors Sales by Region (2021-2026) & (K Units) Table 20. Global PD-L1 Inhibitors Sales by Region (2027-2032) & (K Units) Table 21. Global PD-L1 Inhibitors Sales Market Share by Region (2021-2026) Table 22. Global PD-L1 Inhibitors Sales Market Share by Region (2027-2032) Table 23. Global PD-L1 Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global PD-L1 Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 25. Global PD-L1 Inhibitors Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global PD-L1 Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 27. Global PD-L1 Inhibitors Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global PD-L1 Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global PD-L1 Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global PD-L1 Inhibitors Manufacturers, Product Type & Application Table 31. Global PD-L1 Inhibitors Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global PD-L1 Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global PD-L1 Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global PD-L1 Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 36. Global PD-L1 Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 37. Global PD-L1 Inhibitors Revenue Market Share by Type (2021-2026) Table 38. Global PD-L1 Inhibitors Revenue Market Share by Type (2027-2032) Table 39. Global PD-L1 Inhibitors Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global PD-L1 Inhibitors Sales by Type (2021-2026) & (K Units) Table 41. Global PD-L1 Inhibitors Sales by Type (2027-2032) & (K Units) Table 42. Global PD-L1 Inhibitors Sales Market Share by Type (2021-2026) Table 43. Global PD-L1 Inhibitors Sales Market Share by Type (2027-2032) Table 44. Global PD-L1 Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 45. Global PD-L1 Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 46. Global PD-L1 Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global PD-L1 Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 48. Global PD-L1 Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 49. Global PD-L1 Inhibitors Revenue Market Share by Application (2021-2026) Table 50. Global PD-L1 Inhibitors Revenue Market Share by Application (2027-2032) Table 51. Global PD-L1 Inhibitors Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global PD-L1 Inhibitors Sales by Application (2021-2026) & (K Units) Table 53. Global PD-L1 Inhibitors Sales by Application (2027-2032) & (K Units) Table 54. Global PD-L1 Inhibitors Sales Market Share by Application (2021-2026) Table 55. Global PD-L1 Inhibitors Sales Market Share by Application (2027-2032) Table 56. Global PD-L1 Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 57. Global PD-L1 Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 58. Merck KGaA Company Information Table 59. Merck KGaA Business Overview Table 60. Merck KGaA PD-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Merck KGaA PD-L1 Inhibitors Product Portfolio Table 62. Merck KGaA Recent Development Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche PD-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Roche PD-L1 Inhibitors Product Portfolio Table 67. Roche Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca PD-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. AstraZeneca PD-L1 Inhibitors Product Portfolio Table 72. AstraZeneca Recent Development Table 73. North America PD-L1 Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 74. North America PD-L1 Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 75. North America PD-L1 Inhibitors Sales by Type (2021-2026) & (K Units) Table 76. North America PD-L1 Inhibitors Sales by Type (2027-2032) & (K Units) Table 77. North America PD-L1 Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 78. North America PD-L1 Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 79. North America PD-L1 Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 80. North America PD-L1 Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 81. North America PD-L1 Inhibitors Sales by Application (2021-2026) & (K Units) Table 82. North America PD-L1 Inhibitors Sales by Application (2027-2032) & (K Units) Table 83. North America PD-L1 Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 84. North America PD-L1 Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 85. North America PD-L1 Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America PD-L1 Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 87. North America PD-L1 Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 88. North America PD-L1 Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 89. North America PD-L1 Inhibitors Sales by Country (2021-2026) & (K Units) Table 90. North America PD-L1 Inhibitors Sales by Country (2027-2032) & (K Units) Table 91. North America PD-L1 Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 92. North America PD-L1 Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 93. United States PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 94. Canada PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 95. Europe PD-L1 Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe PD-L1 Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe PD-L1 Inhibitors Sales by Type (2021-2026) & (K Units) Table 98. Europe PD-L1 Inhibitors Sales by Type (2027-2032) & (K Units) Table 99. Europe PD-L1 Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe PD-L1 Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe PD-L1 Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe PD-L1 Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe PD-L1 Inhibitors Sales by Application (2021-2026) & (K Units) Table 104. Europe PD-L1 Inhibitors Sales by Application (2027-2032) & (K Units) Table 105. Europe PD-L1 Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe PD-L1 Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe PD-L1 Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe PD-L1 Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe PD-L1 Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe PD-L1 Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe PD-L1 Inhibitors Sales by Country (2021-2026) & (K Units) Table 112. Europe PD-L1 Inhibitors Sales by Country (2027-2032) & (K Units) Table 113. Europe PD-L1 Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe PD-L1 Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 116. France PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 117. U.K. PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 118. Italy PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 119. Netherlands PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 120. China PD-L1 Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 121. China PD-L1 Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 122. China PD-L1 Inhibitors Sales by Type (2021-2026) & (K Units) Table 123. China PD-L1 Inhibitors Sales by Type (2027-2032) & (K Units) Table 124. China PD-L1 Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 125. China PD-L1 Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 126. China PD-L1 Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 127. China PD-L1 Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 128. China PD-L1 Inhibitors Sales by Application (2021-2026) & (K Units) Table 129. China PD-L1 Inhibitors Sales by Application (2027-2032) & (K Units) Table 130. China PD-L1 Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 131. China PD-L1 Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia PD-L1 Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia PD-L1 Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia PD-L1 Inhibitors Sales by Type (2021-2026) & (K Units) Table 135. Asia PD-L1 Inhibitors Sales by Type (2027-2032) & (K Units) Table 136. Asia PD-L1 Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 137. Asia PD-L1 Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 138. Asia PD-L1 Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia PD-L1 Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia PD-L1 Inhibitors Sales by Application (2021-2026) & (K Units) Table 141. Asia PD-L1 Inhibitors Sales by Application (2027-2032) & (K Units) Table 142. Asia PD-L1 Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 143. Asia PD-L1 Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia PD-L1 Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia PD-L1 Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia PD-L1 Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia PD-L1 Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. Asia PD-L1 Inhibitors Sales by Country (2021-2026) & (K Units) Table 149. Asia PD-L1 Inhibitors Sales by Country (2027-2032) & (K Units) Table 150. Asia PD-L1 Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 151. Asia PD-L1 Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 152. Japan PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 153. South Korea PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 154. India PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 155. Australia PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 156. China Taiwan PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 158. SAMEA PD-L1 Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA PD-L1 Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA PD-L1 Inhibitors Sales by Type (2021-2026) & (K Units) Table 161. SAMEA PD-L1 Inhibitors Sales by Type (2027-2032) & (K Units) Table 162. SAMEA PD-L1 Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 163. SAMEA PD-L1 Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 164. SAMEA PD-L1 Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA PD-L1 Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA PD-L1 Inhibitors Sales by Application (2021-2026) & (K Units) Table 167. SAMEA PD-L1 Inhibitors Sales by Application (2027-2032) & (K Units) Table 168. SAMEA PD-L1 Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 169. SAMEA PD-L1 Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 170. SAMEA PD-L1 Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA PD-L1 Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA PD-L1 Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA PD-L1 Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. SAMEA PD-L1 Inhibitors Sales by Country (2021-2026) & (K Units) Table 175. SAMEA PD-L1 Inhibitors Sales by Country (2027-2032) & (K Units) Table 176. SAMEA PD-L1 Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 177. SAMEA PD-L1 Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Brazil PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 179. Argentina PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 180. Chile PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 181. Colombia PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 182. Peru PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 184. Israel PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 185. UAE PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 186. Turkey PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 187. Iran PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 188. Egypt PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. PD-L1 Inhibitors Distributors List Table 192. PD-L1 Inhibitors Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. PD-L1 Inhibitors Image Figure 2. Global PD-L1 Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PD-L1 Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 4. TECENTRIQ Image Figure 5. Imfinzi Image Figure 6. Bavencio Image Figure 7. Global PD-L1 Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global PD-L1 Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 9. Retail Pharmacy Image Figure 10. Hospital Pharmacy Image Figure 11. Other Image Figure 12. Global PD-L1 Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global PD-L1 Inhibitors Revenue (2021-2032) & (US$ Million) Figure 14. Global PD-L1 Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global PD-L1 Inhibitors Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global PD-L1 Inhibitors Revenue Market Share by Region (2021-2032) Figure 17. Global PD-L1 Inhibitors Sales (2021-2032) & (K Units) Figure 18. Global PD-L1 Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global PD-L1 Inhibitors Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico PD-L1 Inhibitors Sales YoY (2021-2032) & (K Units) Figure 21. Europe PD-L1 Inhibitors Sales YoY (2021-2032) & (K Units) Figure 22. China PD-L1 Inhibitors Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) PD-L1 Inhibitors Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa PD-L1 Inhibitors Sales YoY (2021-2032) & (K Units) Figure 25. Global PD-L1 Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global PD-L1 Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global PD-L1 Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global PD-L1 Inhibitors Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global PD-L1 Inhibitors Revenue Market Share by Type (2021-2032) Figure 31. Global PD-L1 Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global PD-L1 Inhibitors Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global PD-L1 Inhibitors Sales Market Share by Type (2021-2032) Figure 34. Global PD-L1 Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global PD-L1 Inhibitors Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global PD-L1 Inhibitors Revenue Market Share by Application (2021-2032) Figure 37. Global PD-L1 Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global PD-L1 Inhibitors Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global PD-L1 Inhibitors Sales Market Share by Application (2021-2032) Figure 40. North America PD-L1 Inhibitors Revenue Share by Type (2021-2032) Figure 41. North America PD-L1 Inhibitors Sales Share by Type (2021-2032) Figure 42. North America PD-L1 Inhibitors Revenue Share by Application (2021-2032) Figure 43. North America PD-L1 Inhibitors Sales Share by Application (2021-2032) Figure 44. North America PD-L1 Inhibitors Revenue Share by Country (2021-2032) Figure 45. North America PD-L1 Inhibitors Sales Share by Country (2021-2032) Figure 46. Europe PD-L1 Inhibitors Revenue Share by Type (2021-2032) Figure 47. Europe PD-L1 Inhibitors Sales Share by Type (2021-2032) Figure 48. Europe PD-L1 Inhibitors Revenue Share by Application (2021-2032) Figure 49. Europe PD-L1 Inhibitors Sales Share by Application (2021-2032) Figure 50. Europe PD-L1 Inhibitors Revenue Share by Country (2021-2032) Figure 51. Europe PD-L1 Inhibitors Sales Share by Country (2021-2032) Figure 52. China PD-L1 Inhibitors Revenue Share by Type (2021-2032) Figure 53. China PD-L1 Inhibitors Sales Share by Type (2021-2032) Figure 54. China PD-L1 Inhibitors Revenue Share by Application (2021-2032) Figure 55. China PD-L1 Inhibitors Sales Share by Application (2021-2032) Figure 56. Asia PD-L1 Inhibitors Revenue Share by Type (2021-2032) Figure 57. Asia PD-L1 Inhibitors Sales Share by Type (2021-2032) Figure 58. Asia PD-L1 Inhibitors Revenue Share by Application (2021-2032) Figure 59. Asia PD-L1 Inhibitors Sales Share by Application (2021-2032) Figure 60. Asia PD-L1 Inhibitors Revenue Share by Country (2021-2032) Figure 61. Asia PD-L1 Inhibitors Sales Share by Country (2021-2032) Figure 62. SAMEA PD-L1 Inhibitors Revenue Share by Type (2021-2032) Figure 63. SAMEA PD-L1 Inhibitors Sales Share by Type (2021-2032) Figure 64. SAMEA PD-L1 Inhibitors Revenue Share by Application (2021-2032) Figure 65. SAMEA PD-L1 Inhibitors Sales Share by Application (2021-2032) Figure 66. SAMEA PD-L1 Inhibitors Revenue Share by Country (2021-2032) Figure 67. SAMEA PD-L1 Inhibitors Sales Share by Country (2021-2032) Figure 68. PD-L1 Inhibitors Value Chain Figure 69. Manufacturing Cost Structure Figure 70. PD-L1 Inhibitors Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • TECENTRIQ
  • Imfinzi
  • Bavencio
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Other
Companies covered
  • Merck KGaA
  • Roche
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 PD-L1 Inhibitors Market by Type
  3. 1.2.1 Global PD-L1 Inhibitors Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 TECENTRIQ
  5. 1.2.3 Imfinzi
  6. 1.2.4 Bavencio
  7. 1.3 PD-L1 Inhibitors Market by Application
  8. 1.3.1 Global PD-L1 Inhibitors Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacy
  10. 1.3.3 Hospital Pharmacy
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 PD-L1 Inhibitors Market Dynamics
  1. 2.1 PD-L1 Inhibitors Industry Trends
  2. 2.2 PD-L1 Inhibitors Industry Drivers
  3. 2.3 PD-L1 Inhibitors Industry Opportunities and Challenges
  4. 2.4 PD-L1 Inhibitors Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global PD-L1 Inhibitors Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global PD-L1 Inhibitors Revenue by Region
  3. 3.2.1 Global PD-L1 Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global PD-L1 Inhibitors Revenue by Region (2021-2026)
  5. 3.2.3 Global PD-L1 Inhibitors Revenue by Region (2027-2032)
  6. 3.2.4 Global PD-L1 Inhibitors Revenue Market Share by Region (2021-2032)
  7. 3.3 Global PD-L1 Inhibitors Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global PD-L1 Inhibitors Sales by Region
  9. 3.4.1 Global PD-L1 Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global PD-L1 Inhibitors Sales by Region (2021-2026)
  11. 3.4.3 Global PD-L1 Inhibitors Sales by Region (2027-2032)
  12. 3.4.4 Global PD-L1 Inhibitors Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global PD-L1 Inhibitors Revenue by Manufacturers
  2. 4.1.1 Global PD-L1 Inhibitors Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global PD-L1 Inhibitors Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global PD-L1 Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global PD-L1 Inhibitors Sales by Manufacturers
  6. 4.2.1 Global PD-L1 Inhibitors Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global PD-L1 Inhibitors Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global PD-L1 Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global PD-L1 Inhibitors Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global PD-L1 Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global PD-L1 Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global PD-L1 Inhibitors Manufacturers, Product Type & Application
  13. 4.7 Global PD-L1 Inhibitors Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global PD-L1 Inhibitors Market CR5 and HHI
  16. 4.8.2 2025 PD-L1 Inhibitors Tier 1, Tier 2, and Tier 3
5 PD-L1 Inhibitors Market by Type
  1. 5.1 Global PD-L1 Inhibitors Revenue by Type
  2. 5.1.1 Global PD-L1 Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global PD-L1 Inhibitors Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global PD-L1 Inhibitors Revenue Market Share by Type (2021-2032)
  5. 5.2 Global PD-L1 Inhibitors Sales by Type
  6. 5.2.1 Global PD-L1 Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global PD-L1 Inhibitors Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global PD-L1 Inhibitors Sales Market Share by Type (2021-2032)
  9. 5.3 Global PD-L1 Inhibitors Price by Type
6 PD-L1 Inhibitors Market by Application
  1. 6.1 Global PD-L1 Inhibitors Revenue by Application
  2. 6.1.1 Global PD-L1 Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global PD-L1 Inhibitors Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global PD-L1 Inhibitors Revenue Market Share by Application (2021-2032)
  5. 6.2 Global PD-L1 Inhibitors Sales by Application
  6. 6.2.1 Global PD-L1 Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global PD-L1 Inhibitors Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global PD-L1 Inhibitors Sales Market Share by Application (2021-2032)
  9. 6.3 Global PD-L1 Inhibitors Price by Application
7 Company Profiles
  1. 7.1 Merck KGaA
  2. 7.1.1 Merck KGaA Company Information
  3. 7.1.2 Merck KGaA Business Overview
  4. 7.1.3 Merck KGaA PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck KGaA PD-L1 Inhibitors Product Portfolio
  6. 7.1.5 Merck KGaA Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Roche PD-L1 Inhibitors Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 AstraZeneca
  14. 7.3.1 AstraZeneca Company Information
  15. 7.3.2 AstraZeneca Business Overview
  16. 7.3.3 AstraZeneca PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AstraZeneca PD-L1 Inhibitors Product Portfolio
  18. 7.3.5 AstraZeneca Recent Developments
8 North America
  1. 8.1 North America PD-L1 Inhibitors Market Size by Type
  2. 8.1.1 North America PD-L1 Inhibitors Revenue by Type (2021-2032)
  3. 8.1.2 North America PD-L1 Inhibitors Sales by Type (2021-2032)
  4. 8.1.3 North America PD-L1 Inhibitors Price by Type (2021-2032)
  5. 8.2 North America PD-L1 Inhibitors Market Size by Application
  6. 8.2.1 North America PD-L1 Inhibitors Revenue by Application (2021-2032)
  7. 8.2.2 North America PD-L1 Inhibitors Sales by Application (2021-2032)
  8. 8.2.3 North America PD-L1 Inhibitors Price by Application (2021-2032)
  9. 8.3 North America PD-L1 Inhibitors Market Size by Country
  10. 8.3.1 North America PD-L1 Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America PD-L1 Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America PD-L1 Inhibitors Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe PD-L1 Inhibitors Market Size by Type
  2. 9.1.1 Europe PD-L1 Inhibitors Revenue by Type (2021-2032)
  3. 9.1.2 Europe PD-L1 Inhibitors Sales by Type (2021-2032)
  4. 9.1.3 Europe PD-L1 Inhibitors Price by Type (2021-2032)
  5. 9.2 Europe PD-L1 Inhibitors Market Size by Application
  6. 9.2.1 Europe PD-L1 Inhibitors Revenue by Application (2021-2032)
  7. 9.2.2 Europe PD-L1 Inhibitors Sales by Application (2021-2032)
  8. 9.2.3 Europe PD-L1 Inhibitors Price by Application (2021-2032)
  9. 9.3 Europe PD-L1 Inhibitors Market Size by Country
  10. 9.3.1 Europe PD-L1 Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe PD-L1 Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe PD-L1 Inhibitors Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China PD-L1 Inhibitors Market Size by Type
  2. 10.1.1 China PD-L1 Inhibitors Revenue by Type (2021-2032)
  3. 10.1.2 China PD-L1 Inhibitors Sales by Type (2021-2032)
  4. 10.1.3 China PD-L1 Inhibitors Price by Type (2021-2032)
  5. 10.2 China PD-L1 Inhibitors Market Size by Application
  6. 10.2.1 China PD-L1 Inhibitors Revenue by Application (2021-2032)
  7. 10.2.2 China PD-L1 Inhibitors Sales by Application (2021-2032)
  8. 10.2.3 China PD-L1 Inhibitors Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia PD-L1 Inhibitors Market Size by Type
  2. 11.1.1 Asia PD-L1 Inhibitors Revenue by Type (2021-2032)
  3. 11.1.2 Asia PD-L1 Inhibitors Sales by Type (2021-2032)
  4. 11.1.3 Asia PD-L1 Inhibitors Price by Type (2021-2032)
  5. 11.2 Asia PD-L1 Inhibitors Market Size by Application
  6. 11.2.1 Asia PD-L1 Inhibitors Revenue by Application (2021-2032)
  7. 11.2.2 Asia PD-L1 Inhibitors Sales by Application (2021-2032)
  8. 11.2.3 Asia PD-L1 Inhibitors Price by Application (2021-2032)
  9. 11.3 Asia PD-L1 Inhibitors Market Size by Country
  10. 11.3.1 Asia PD-L1 Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia PD-L1 Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia PD-L1 Inhibitors Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA PD-L1 Inhibitors Market Size by Type
  2. 12.1.1 SAMEA PD-L1 Inhibitors Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA PD-L1 Inhibitors Sales by Type (2021-2032)
  4. 12.1.3 SAMEA PD-L1 Inhibitors Price by Type (2021-2032)
  5. 12.2 SAMEA PD-L1 Inhibitors Market Size by Application
  6. 12.2.1 SAMEA PD-L1 Inhibitors Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA PD-L1 Inhibitors Sales by Application (2021-2032)
  8. 12.2.3 SAMEA PD-L1 Inhibitors Price by Application (2021-2032)
  9. 12.3 SAMEA PD-L1 Inhibitors Market Size by Country
  10. 12.3.1 SAMEA PD-L1 Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA PD-L1 Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA PD-L1 Inhibitors Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 PD-L1 Inhibitors Value Chain Analysis
  2. 13.1.1 PD-L1 Inhibitors Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 PD-L1 Inhibitors Production Mode & Process
  6. 13.2 PD-L1 Inhibitors Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 PD-L1 Inhibitors Distributors
  9. 13.2.3 PD-L1 Inhibitors Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst